Publications by Medical Specialty - Endocrinology, Diabetes & Metabolism
These publications were authored or co-authored by Quest Diagnostics staff.
- Clinical and Lab healthcare professionals
- Endocrinology, Diabetes & Metabolism
- Family medicine practitioners
- General Health and Wellness
- Geriatrics/Age Management
- Health Information Technology
- Infectious Disease
- Internal Medicine
- Nurse practitioners
- Pathology, Anatomic
- Pathology, Laboratory Medicine
- Physician assistants
- Sports Medicine
- Toxicology/Pain Management
- Women's Health/OB/GYN
Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis
Authors: Shiffman D, Arellano AR, Caulfield MP, Louie JZ, Bare LA, Devlin JJ, Melander O
BMC Cardiovascular Disorders 2016; 16:251
A Young Woman With Recurrent Gestational Hypercalcemia and Acute Pancreatitis Caused by CYP24A1 Deficiency.
Authors: Woods GN, Saitman A, Gao H, Clarke NJ, Fitzgerald RL, Chi NW
J Bone Miner Res. 2016;31:1841-1844.
Authors: Chambers C, Fouts A, Dong F, Colclough K, Wang Z, Batish SD, Jaremko M, Ellard S, Hattersley AT, Klingensmith G, Steck AK.
Pediatr Diabetes. 2016;17:360-7.
Authors: Taylor SW, Clarke NJ, McPhaul MJ.
Clin Chem. 2016;62:1152-1153
Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women.
Authors: Palmer JR, Gerlovin H, Bethea TN, Bertrand KA, Holick MF, Ruiz-Narvaez EN, Wise LA, Haddad SA, Adams-Campbell LL, Kaufman HW, Rosenberg L, Cozier YC
Breast Cancer Res. 2016;18:86
Authors: Taylor SW, Clarke NJ, Chen Z, McPhaul MJ.
Clin Chim Acta. 2016;455:202-208
Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Authors: Bril F, Sninsky JJ, Baca AM, Superko HR, Portillo Sanchez P, Biernacki D, Maximos M, Lomonaco R, Orsak B,Suman A, Weber MH, McPhaul MJ, Cusi K.
J Clin Endocrinol Metab. 2016;101:644-652
Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
Authors: Mora S, Caulfield MP, Wohlgemuth J, Chen Z, Superko HR, Rowland CM, Glynn RJ, Ridker PM, Krauss RM
Quest Diagnostics Authors: Elston, D
Authors: Bandino JP, Kazlouskaya V, Ergin S, Moles-Proveda P, Cleaver NJ, Kabigting FD, Shackelton JB, Thieu K
J Cutan Pathol 2015